Clinical Trials for Chronic Spontaneous Urticaria

Find clinical trials for chronic spontaneous urticaria. Discover research opportunities and treatment options in your area.

21 Active Trials Found

Showing 21 trials on this page

Page 1 of 2

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

NCT ID: NCT06931405

This clinical trial is studying a new medication called BLU-808, which is being tested for its safety and effectiveness in people with chronic urticaria conditions. There are two parts to the study...

Recruiting

Phase: PHASE2 Type: interventional Locations: Pittsburgh, Pennsylvania, United States, San Diego, California, United States +7 more

Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

NCT ID: NCT06873516

This clinical trial is looking at a new treatment called EVO756 for adults who have moderate to severe chronic spontaneous urticaria (CSU), a condition that causes itchy hives without a clear cause...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States, Fremont, California, United States +39 more

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

NCT ID: NCT05677451

This clinical trial is investigating a new treatment called remibrutinib for adolescents aged 12 to less than 18 years who have chronic spontaneous urticaria (CSU), which means they experience itch...

Recruiting

Phase: PHASE3 Type: interventional Locations: Frankfurt Am Main, Hessen, Germany, Utrecht, , Netherlands +82 more

Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

NCT ID: NCT06042478

This clinical trial is studying a new medication called remibrutinib for adults with chronic spontaneous urticaria (CSU), a condition that causes itchy hives. The trial will compare remibrutinib to...

Recruiting

Phase: PHASE3 Type: interventional Locations: Frankfurt Am Main, Hessen, Germany, Utrecht, , Netherlands +141 more

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of BGB-16673 in Adults With Chronic Spontaneous Urticaria

NCT ID: NCT07005713

This clinical trial is designed to test a new medication called BGB-16673 in adults who have a condition known as chronic spontaneous urticaria (CSU), which causes persistent itching and hives. The...

Not yet recruiting

Phase: PHASE1 Type: interventional

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

NCT ID: NCT06455202

This clinical trial is studying a new treatment called barzolvolimab for adults suffering from Chronic Spontaneous Urticaria (CSU), which is a condition where people experience itchy hives without ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Boston, Massachusetts, United States, Westmead, New South Wales, Australia +183 more

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT ID: NCT03661866

The TARGET-DERM study is looking at how well current and future treatments work for people with skin conditions like Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasi...

Recruiting

Type: observational Locations: Rochester, Minnesota, United States, Minneapolis, Minnesota, United States +64 more

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

NCT ID: NCT06445023

This clinical trial is studying a new treatment called barzolvolimab for adults with chronic spontaneous urticaria (CSU), a condition that causes itchy hives that can last for a long time. The goal...

Recruiting

Phase: PHASE3 Type: interventional Locations: Gent, , Belgium, Madrid, , Spain +201 more

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.

NCT ID: NCT06864507

This clinical trial is studying a new medication called HS-10561, used to see if it is safe and effective for treating chronic spontaneous urticaria (CSU), a condition that causes itchy hives witho...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)

NCT ID: NCT06162728

This clinical trial is studying a new medication called briquilimab for adults with chronic spontaneous urticaria (CSU), a condition that causes persistent itching and hives. The trial aims to find...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States, Murray, Utah, United States +44 more

Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria

NCT ID: NCT06795373

This clinical trial is studying a medication called ritlecitinib to see if it is safe and effective for people with chronic spontaneous urticaria (CSU), which is a condition that causes hives and i...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States

A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China

NCT ID: NCT06053801

This clinical trial is studying the safety and effectiveness of a medication called Xolair® for children and teenagers in China who have Chronic Spontaneous Urticaria (CSU) but are still experienci...

Recruiting

Type: observational Locations: Nantong, Jiangsu, China, Shanghai, , China +1 more

A Study of Efficacy and Safety of TLL-018 in CSU Participants

NCT ID: NCT06396026

This clinical trial is studying a new treatment called TLL-018 for people with Chronic Spontaneous Urticaria (CSU), a condition that causes itchy hives without a known cause. The goal is to see if ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Nanjing, Jiangsu, China

Trial of JYB1904 in Chronic Spontaneous Urticaria.

NCT ID: NCT06509334

This clinical trial is studying a new treatment called JYB1904 for adults with Chronic Spontaneous Urticaria (CSU), a condition that causes persistent itching and hives without a known cause. The t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

A Study of Single Dose of LP-003 in Healthy Adult Subjects

NCT ID: NCT06604949

This clinical trial is designed to study a new medication called LP-003 in healthy adults. The main goal is to understand how safe it is, how well it works, and how the body processes it. The trial...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China

Extending Omalizumab Treatment Intervals in Patients with Chronic Spontaneous Urticaria

NCT ID: NCT05916937

This clinical trial is studying whether patients with chronic spontaneous urticaria (CSU), a condition that causes itchy hives without a known cause, can safely extend the time between their omaliz...

Recruiting

Phase: PHASE4 Type: interventional Locations: Copenhagen, Copenhagen N, Denmark

To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria

NCT ID: NCT06365879

This clinical trial is looking to compare two treatments for a condition called Chronic Spontaneous Urticaria (CSU), which causes itchy hives and can be very uncomfortable. The trial will test a ne...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, , China

A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria

NCT ID: NCT06295302

This clinical trial is studying a new medication called HWH486 to see if it is safe and effective for adults suffering from chronic spontaneous urticaria (CSU), a condition that causes persistent i...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chengdu, Sichuan, China

Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment

NCT ID: NCT06228560

This clinical trial is studying a new treatment called LP-003 for adults aged 18 to 75 who have chronic spontaneous urticaria (CSU), a condition that causes itchy hives, and who still have symptoms...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China, Beijing, Beijing, China +15 more

Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU)

NCT ID: NCT06250400

This clinical trial is looking at a new treatment for people with chronic spontaneous urticaria (CSU), a condition that causes itchy hives without a known reason. The treatment being studied is cal...

Not yet recruiting

Phase: PHASE4 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions